High-dose oral baclofen: experience in patients with multiple sclerosis.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 1944915.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We reviewed a 10% random sample of charts from an outpatient clinic for multiple sclerosis to determine the frequency with which baclofen was prescribed for spasticity in high doses (greater than 80 mg/d). About 20% of patients had taken high-dose baclofen, and 15% were still receiving a high dose. Taking a high dose was not associated with discontinuing treatment.
Medical subject headings
- Baclofen
- Multiple Sclerosis